NCT01203748

Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Star AF II Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 589 (actual)
• Sponsor: Abbott Medical Devices · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This investigation is designed with the hypothesis that combined PV Antral Isolation and Ablation of Complex Fractionated Electrograms (PVI+CFE) approach will offer a higher success rate compared to the Wide Circumferential Pulmonary Vein Antrum Isolation (PVI) approach and to the Combined PV Antral Isolation and Empiric Linear Ablation (PVI+Lines) approach.

Conditions

• Atrial Fibrillation

Interventions

Type	Name	Description
PROCEDURE	PVI + Lines ablation	Pulmonary vein antrum isolation with additional linear ablation (mitral line and roof line)
PROCEDURE	PVI	Pulmonary vein antrum isolation
PROCEDURE	PVI + CFE ablation	Pulmonary vein antrum isolation with additional complex fractionated electrogram ablation

Timeline

• Start date: 2010-11-01
• Primary completion: 2014-01-01
• Completion: 2014-01-01
• First posted: 2010-09-16
• Last updated: 2019-01-30

Locations

2 sites across 2 countries: Australia, Canada